Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidemiologic studies of Parkinson's disease. 3. A community-based survey.

Literature DB >> 5074681

Epidemiologic studies of Parkinson's disease. 3. A community-based survey.

I I Kessler.

Abstract

Entities: Disease

Mesh：

Year: 1972 PMID： 5074681 DOI： 10.1093/oxfordjournals.aje.a121455

Source DB: PubMed Journal: Am J Epidemiol ISSN： 0002-9262 Impact factor: 4.897

Keyword Cloud
Cited

× No keyword cloud information.

27 in total

1. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection.

Authors: K Fuxe; A M Janson; A Jansson; K Andersson; P Eneroth; L F Agnati
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1990-03 Impact factor: 3.000

2. Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease.

Authors: Xuemei Huang; Honglei Chen; William C Miller; Richard B Mailman; Jennifer L Woodard; Peter C Chen; Dong Xiang; Richard W Murrow; Yi-Zhe Wang; Charles Poole
Journal: Mov Disord Date: 2007-02-15 Impact factor: 10.338

Review 3. How far are we in understanding the cause of Parkinson's disease?

Authors: Y Ben-Shlomo
Journal: J Neurol Neurosurg Psychiatry Date: 1996-07 Impact factor: 10.154

4. Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study.

Authors: Talene A Yacoubian; George Howard; Brett Kissela; Charles D Sands; David G Standaert
Journal: Neuroepidemiology Date: 2009-11-04 Impact factor: 3.282

Epidemiologic studies of Parkinson's disease. 3. A community-based survey.

1. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection.

2. Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease.

Review 3. How far are we in understanding the cause of Parkinson's disease?

4. Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study.

Review 5. Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease.

6. Influenza and Parkinson's disease.

7. Smoking and Parkinson's disease.

8. Clinical characteristics of Parkinson's disease among Jewish Ethnic groups in Israel.

Review 9. Prevalence of Parkinson's disease in populations of African ancestry: a review.

10. Epidemiology of Parkinson's disease--an overview.